ASTH Stock Closes at $37.95 – Consolidation Phase with 13% Above 200‑Day SMA
Explore Astrana Health’s latest stock move, 12‑month growth plans, and market positioning—why investors are watching its value‑based care strategy.
3 minutes to read
ASTRANA HEALTH INC